IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v148y2024ics0168851024001568.html
   My bibliography  Save this article

Early access programs for medical devices in France: Overview of recent reforms and outcomes (2015-2022)

Author

Listed:
  • Martin, Tess
  • Hervias, Alexandra
  • Armoiry, Xavier
  • Martelli, Nicolas

Abstract

The medical technology sector is characterised by a constant influx of innovations with the potential to revolutionise patient care. In France, there are several pathways for medical devices to enter the market, from diagnosis-related group tariffs to reimbursement lists. However, traditional regulatory pathways can delay market access for innovative technologies. In response, France has established Early Access Programs to expedite patient access to medical devices. This paper looks at three of these Early Access Programs for medical devices. Innovation Funding, introduced in its final version in 2015, provides temporary coverage for innovative devices and facilitates data collection for informed funding decisions. Transitional Coverage (PECT), established in 2021, targets CE-marked devices for rare or serious conditions. Transitional coverage for digital health applications (PECAN), introduced in 2022, covers digital medical devices, either therapeutic or for patient monitoring. Innovation funding has been granted to 16 technologies out of 35 applications (46%) since 2015. 6 technologies out of 11 (64%) applications benefit from PECT. PECAN, in its first year, has granted a telemonitoring solution with a favourable opinion. The French experience could provide valuable lessons for the development of a harmonised European framework to ensure that innovative medical technologies benefit those who need them, while maintaining high safety standards.

Suggested Citation

  • Martin, Tess & Hervias, Alexandra & Armoiry, Xavier & Martelli, Nicolas, 2024. "Early access programs for medical devices in France: Overview of recent reforms and outcomes (2015-2022)," Health Policy, Elsevier, vol. 148(C).
    • Handle: RePEc:eee:hepoli:v:148:y:2024:i:c:s0168851024001568
    DOI: 10.1016/j.healthpol.2024.105146
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168851024001568
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.healthpol.2024.105146?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Bernardo B. N. Strassburg & Alvaro Iribarrem & Hawthorne L. Beyer & Carlos Leandro Cordeiro & Renato Crouzeilles & Catarina C. Jakovac & André Braga Junqueira & Eduardo Lacerda & Agnieszka E. Latawiec, 2020. "Global priority areas for ecosystem restoration," Nature, Nature, vol. 586(7831), pages 724-729, October.
    2. Charles M. A. Clark, 2020. "On the Priority of Labor Over Capital," American Journal of Economics and Sociology, Wiley Blackwell, vol. 79(4), pages 1147-1180, September.
    3. Michael Drummond & Carlo Federici & Vivian Reckers‐Droog & Aleksandra Torbica & Carl Rudolf Blankart & Oriana Ciani & Zoltán Kaló & Sándor Kovács & Werner Brouwer, 2022. "Coverage with evidence development for medical devices in Europe: Can practice meet theory?," Health Economics, John Wiley & Sons, Ltd., vol. 31(S1), pages 179-194, September.
    4. Sorenson, Corinna & Kanavos, Panos, 2011. "Medical technology procurement in Europe: A cross-country comparison of current practice and policy," Health Policy, Elsevier, vol. 100(1), pages 43-50, April.
    5. Siqiao Li & Ger Koole & Xiaolan Xie, 2020. "An adaptive priority policy for radiotherapy scheduling," Flexible Services and Manufacturing Journal, Springer, vol. 32(1), pages 154-180, March.
    6. Sorenson, Corinna & Chalkidou, Kalipso, 2012. "Reflections on the evolution of health technology assessment in Europe," Health Economics, Policy and Law, Cambridge University Press, vol. 7(1), pages 25-45, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Miller, Fiona A. & Lehoux, Pascale & Rac, Valeria E. & Bytautas, Jessica P. & Krahn, Murray & Peacock, Stuart, 2020. "Modes of coordination for health technology adoption: Health Technology Assessment agencies and Group Procurement Organizations in a polycentric regulatory regime," Social Science & Medicine, Elsevier, vol. 265(C).
    2. Rachet-Jacquet, Laurie & Toulemon, Léa & Rochaix, Lise, 2021. "Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List," Health Policy, Elsevier, vol. 125(7), pages 923-929.
    3. Klingler, Corinna & Shah, Sara M.B. & Barron, Anthony J.G. & Wright, John S.F., 2013. "Regulatory space and the contextual mediation of common functional pressures: Analyzing the factors that led to the German Efficiency Frontier approach," Health Policy, Elsevier, vol. 109(3), pages 270-280.
    4. Pedro Parreira & Liliana B. Sousa & Inês A. Marques & Paulo Santos-Costa & Sara Cortez & Filipa Carneiro & Arménio Cruz & Anabela Salgueiro-Oliveira, 2020. "Study Protocol for Two-Steps Parallel Randomized Controlled Trial: Pre-Clinical Usability Tests for a New Double-Chamber Syringe," IJERPH, MDPI, vol. 17(22), pages 1-11, November.
    5. Kisser, Agnes & Tüchler, Heinz & Erdös, Judit & Wild, Claudia, 2016. "Factors influencing coverage decisions on medical devices: A retrospective analysis of 78 medical device appraisals for the Austrian hospital benefit catalogue 2008–2015," Health Policy, Elsevier, vol. 120(8), pages 903-912.
    6. Katharina Elisabeth Blankart & Tom Stargardt, 2020. "The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany," Health Economics, John Wiley & Sons, Ltd., vol. 29(S1), pages 63-82, October.
    7. Dubas-Jakóbczyk, K. & Albreht, T. & Behmane, D. & Bryndova, L. & Dimova, A. & Džakula, A. & Habicht, T. & Murauskiene, L. & Scîntee, S.G. & Smatana, M. & Velkey, Z. & Quentin, W., 2020. "Hospital reforms in 11 Central and Eastern European countries between 2008 and 2019: a comparative analysis," Health Policy, Elsevier, vol. 124(4), pages 368-379.
    8. Anantha, K.H. & Garg, Kaushal K. & Barron, Jennie & Dixit, Sreenath & Venkataradha, A. & Singh, Ramesh & Whitbread, Anthony M., 2021. "Impact of best management practices on sustainable crop production and climate resilience in smallholder farming systems of South Asia," Agricultural Systems, Elsevier, vol. 194(C).
    9. G. Crea & A. Cavaliere & A. Cozzi, 2019. "Price discrimination in the Italian medical device industry: an empirical analysis," Economia Politica: Journal of Analytical and Institutional Economics, Springer;Fondazione Edison, vol. 36(2), pages 571-608, July.
    10. Latinovic, Zoran & Chatterjee, Sharmila C., 2024. "Value co-creation: Balancing B2B platform value and potential reverse-value effects," Journal of Business Research, Elsevier, vol. 175(C).
    11. repec:bla:glopol:v:8:y:2017:i:s2:p:69-75 is not listed on IDEAS
    12. Vera, Ivan & Wicke, Birka & Lamers, Patrick & Cowie, Annette & Repo, Anna & Heukels, Bas & Zumpf, Colleen & Styles, David & Parish, Esther & Cherubini, Francesco & Berndes, Göran & Jager, Henriette & , 2022. "Land use for bioenergy: Synergies and trade-offs between sustainable development goals," Renewable and Sustainable Energy Reviews, Elsevier, vol. 161(C).
    13. Gentilini, Arianna & Miraldo, Marisa, 2023. "The role of patient organisations in research and development: Evidence from rare diseases," Social Science & Medicine, Elsevier, vol. 338(C).
    14. Lea Toulemon, 2018. "The effect of group purchasing on prices hospitals pay for medicines," Health Economics, John Wiley & Sons, Ltd., vol. 27(9), pages 1380-1393, September.
    15. Miller, Fiona A. & Lehoux, Pascale, 2020. "The innovation impacts of public procurement offices: The case of healthcare procurement," Research Policy, Elsevier, vol. 49(7).
    16. Rana, Pushpendra & Fleischman, Forrest & Ramprasad, Vijay & Lee, Kangjae, 2022. "Predicting wasteful spending in tree planting programs in Indian Himalaya," World Development, Elsevier, vol. 154(C).
    17. repec:spo:wpmain:info:hdl:2441/3018m4nhj18vvr47bolsnnqeqs is not listed on IDEAS
    18. repec:hal:spmain:info:hdl:2441/3018m4nhj18vvr47bolsnnqeqs is not listed on IDEAS
    19. Maximilian H. M. Hatz & Jonas Schreyögg & Aleksandra Torbica & Giuseppe Boriani & Carl R. B. Blankart, 2017. "Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey," Health Economics, John Wiley & Sons, Ltd., vol. 26(S1), pages 124-144, February.
    20. Carroll, Carlos & Ray, Justina, 2021. "Maximizing the effectiveness of national commitments to protected area expansion for conserving biodiversity and ecosystem carbon under climate change," SocArXiv snk95_v1, Center for Open Science.
    21. Matthew Grennan & Robert J. Town, 2020. "Regulating Innovation with Uncertain Quality: Information, Risk, and Access in Medical Devices," American Economic Review, American Economic Association, vol. 110(1), pages 120-161, January.
    22. Narkis S. Morales & Ignacio C. Fernández & Leonardo P. Durán & Waldo A. Pérez-Martínez, 2023. "RePlant Alfa: Integrating Google Earth Engine and R Coding to Support the Identification of Priority Areas for Ecological Restoration," Land, MDPI, vol. 12(2), pages 1-13, January.
    23. Kastanioti, Catherine & Kontodimopoulos, Nick & Stasinopoulos, Dionysis & Kapetaneas, Nikolaos & Polyzos, Nikolaos, 2013. "Public procurement of health technologies in Greece in an era of economic crisis," Health Policy, Elsevier, vol. 109(1), pages 7-13.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:148:y:2024:i:c:s0168851024001568. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.